AIM
NEO icon

Arcadia Investment Management’s NeoGenomics NEO Stock Holding History

Arcadia Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,241
Closed -$18K – 402
2017
Q1 		$18K Buy
+2,241
New +$18.3K 0.01% 336
2016
Q3 		– Sell
-1,018
Closed -$8K – 402
2016
Q2 		$8K Buy
+1,018
New +$8.16K ﹤0.01% 410

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Arcadia Investment Management's NEO Position: Q2 2017 in Review

Arcadia Investment Management sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 2,241 shares — an estimated $18K sold.

Arcadia Investment Management first reported a position in NEO in Q2 2016 and held it in 2 quarters. The position peaked at $18K in Q1 2017. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

  • Arcadia Investment Management reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
  • Arcadia Investment Management sold 2,241 NeoGenomics shares in Q2 2017, an estimated $18K.
  • Arcadia Investment Management first reported a position in NeoGenomics in Q2 2016 and held it in 2 quarters.
  • Arcadia Investment Management's NeoGenomics position peaked at $18K in Q1 2017.
  • 134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Arcadia Investment Management's 13F filing for Q2 2017, filed 3 Aug 2017.